{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T08:20:18Z","timestamp":1682410818704},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf (DE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13256-016-1069-2","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T12:26:54Z","timestamp":1477312014000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Course of disease in multifocal choroiditis lacking sufficient immunosuppression: a case report"],"prefix":"10.1186","volume":"10","author":[{"given":"Katharina","family":"Schroeder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Meyer-ter-Vehn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Fassnacht-Riederle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Guthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"issue":"4","key":"1069_CR1","first-page":"270","volume":"6","author":"CP Herbort","year":"2011","unstructured":"Herbort CP, Papadia M, Piergiorgio N. Myopia and inflammation. J Ophthalmic Vis Res. 2011;6(4):270\u201383.","journal-title":"J Ophthalmic Vis Res"},{"key":"1069_CR2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/IAE.0b013e31829234cb","volume":"34","author":"AT Fung","year":"2014","unstructured":"Fung AT, et al. Multifocal choroiditis without panuveitis: clinical characteristics and progression. Retina. 2014;34:98\u2013107.","journal-title":"Retina"},{"issue":"1","key":"1069_CR3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/IAE.0b013e318187aff9","volume":"29","author":"H Fine","year":"2009","unstructured":"Fine H, et al. Bevacizumab (Avastin) and ranibizumab (Lucentis) for choroidal neovascularization in multifocal choroiditis. Retina. 2009;29(1):8\u201312.","journal-title":"Retina"},{"key":"1069_CR4","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/IAE.0b013e318275397c","volume":"33","author":"M Parodi","year":"2013","unstructured":"Parodi M, et al. Intravitreal bevacizumab for juxtafoveal choroidal neovascularisation secondary to multifocal choroiditis. Retina. 2013;33:953\u20136.","journal-title":"Retina"},{"key":"1069_CR5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/s-0032-1315249","volume":"229","author":"S Winterhalter","year":"2012","unstructured":"Winterhalter S, et al. Inflammatorische choroidale Neovaskularisationen. Klin Monatsbl Augenheilkunde. 2012;229:897\u2013904.","journal-title":"Klin Monatsbl Augenheilkunde"},{"issue":"3","key":"1069_CR6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcjo.2012.03.042","volume":"47","author":"A Mansour","year":"2012","unstructured":"Mansour A, et al. Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization. Can J Ophthalmol. 2012;47(3):269\u201374.","journal-title":"Can J Ophthalmol"},{"issue":"7","key":"1069_CR7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/IAE.0b013e318286cc77","volume":"33","author":"RF Spaide","year":"2013","unstructured":"Spaide RF, Goldberg N, Freund KB. Redefining multifocal choroiditis and panuveitis and punctate inner choroidopathy through multimodal imaging. Retina. 2013;33(7):1315\u201324.","journal-title":"Retina"},{"key":"1069_CR8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ajo.2013.04.040","volume":"156","author":"SL Baxter","year":"2013","unstructured":"Baxter SL, et al. Risk of Choroidal Neovascularization among the Uveitides. Am J Ophthalmol. 2013;156:468\u201377.","journal-title":"Am J Ophthalmol"},{"key":"1069_CR9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ceo.12008","volume":"40","author":"R Troutbeck","year":"2012","unstructured":"Troutbeck R, et al. Ranibizumab therapy for choroidal neovascularization secondary to non-age-related macular degeneration causes. Clin Exp Ophthalmol. 2012;40:60\u201372.","journal-title":"Clin Exp Ophthalmol"},{"issue":"9","key":"1069_CR10","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/archophthalmol.2010.205","volume":"128","author":"M Parodi","year":"2010","unstructured":"Parodi M, et al. Bevacizumab vs. photodynamic therapy for choroidal neovascularization in multifocal choroiditis. Arch Ophthalmol. 2010;128(9):1100\u20133.","journal-title":"Arch Ophthalmol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-016-1069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:56:40Z","timestamp":1498355800000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-016-1069-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,24]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1069"],"URL":"https:\/\/doi.org\/10.1186\/s13256-016-1069-2","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,24]]},"article-number":"298"}}